, Tracking Stock Market Picks
Enter Symbol:
Stemline Therapeutics Inc. (STML) [hlAlert]

up 31.43 %

Stemline Therapeutics Inc. (STML) rated Sell with price target $9 by WBB Securities

Posted on: Tuesday,  Feb 12, 2013  8:25 AM ET by WBB Securities

WBB Securities rated Sell Stemline Therapeutics Inc. (NASDAQ: STML) on 02/12/2013, when the stock price was $12.00. Since
then, Stemline Therapeutics Inc. has lost 23.92% as of 08/27/2015's recent price of $9.13.
If you would have followed this WBB Securities's recommendation on STML, you would have gained 31.43% of your investment in 926 days.

Research from WBB Securities provides investment professionals with up-to-date, in-depth, accurate and insightful reporting of companies that specialize in biotechnology, medical devices and healthcare. Our goal is to provide independent, straight-forward and up-to-date research so you can make educated decisions about your investments.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/12/2013 8:25 AM Sell
12.00 9.00
as of 12/13/2013
1 Week up  7.68 %
1 Month up  15.19 %
3 Months up  46.65 %
1 YTD down  -64.16 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy